Look for:

Our offer for

ERSTE Multi Fix Coupon Express Bond Biotechnology 20-24


ISIN:
AT0000A2GG90
WKN:
EB0FV4

2023/09/29 17:25:24
Bid Ask
98.10 -
Difference -0.65% (-0.65)

General attributes

IssuerErste Group Bank AG
Product typeExpress bonds
TypeFix Coupon
CurrencyEUR
UnderlyingBIOGEN
AMGEN
Strike Date2020/05/29
Maturity2024/06/01
Coupon/express payment6.250%
Coupon stylefix
Final redemption barrier in %50.00%
Nominal amount1,000.00

PDF download

Final TermsPDF Download
Key Information DocumentPDF Download

Productnews

2020/06/02

Fixing ERSTE Multi Fix Coupon Express Bond Biotechnology 20-24 (AT0000A2GG90)

Add underlying
Interactive chart
Our analysts say...


Performance since inception. Performances under 12 month have only little informative value because of the short maturity. Information about previous performance does not guarantee future performance.
Source: Erste Group Bank AG

Underlyings

Underlying Name and ISINCurrencyPrice underlyingCurrent red. barrCurr.red. barr. dist %Final red. barr.Final red. barr. dist %
BIOGEN
US09062X1037		USD257.01--153.545040.26%
AMGEN
US0311621009		USD268.76--114.850057.27%
Advantages Risks you should be aware of
  • Fixed earnings of 6.25 % per year
  • Possible annual early redemption at 100.00 % of nominal amount
  • Risk buffer (final-redemption-barrier of 50.00 %) compared to a direct investment in the underlyings
  • A fall of the share price below the barrier during the term has no influence on the redemption at the end of the 4th year, relevant is only the price on last valuation date.
  • The exchange rate of the currency of the express bond (EUR) and the currency of the underlyings (USD) has no direct impact on the redemption amount.
  • Erste Group Bank AG will set quotes for this product during the term without being legally obliged to do so.
  • The risk of capital loss depends on the underlying with the worst performance (worst-of). For this product with worst-of structure despite several underlyings there is no risk diversification by spreading the market risk as for a conventional basket product; instead there is a risk concentration.
  • If the closing price of the underlying with the worst performance is below the final-redemption-barrier on the last valuation date, there are losses for the investors. A total loss of invested capital is possible.
  • Investors bear the risk of the issuer Erste Group Bank AG.
  • The earnings are capped at 25.00 %, even if the underlyings perform better.
  • During the term the bond price will not vary 1:1 with the underlyings and premature sale may lead to capital loss.
  • This express bond is not covered by any deposit guarantee scheme. Investors are exposed to the risk that Erste Group Bank AG may not be able to meet its obligations arising from the bond in the event of insolvency or over-indebtedness or from an official order (bail-in regime). A total loss of invested capital is possible.

Secondary market

During the term it is possible to sell the product during the trading hours at the exchanges, where the product is listed.

2023/09/29 17:25:24
Bid Ask
98.10 -
Difference -0.65% (-0.65)

General attributes

IssuerErste Group Bank AG
Product typeExpress bonds
TypeFix Coupon
CurrencyEUR
Stock exchangeVIE, STU
UnderlyingBIOGEN
AMGEN
Issue date2020/06/01
Strike Date2020/05/29
Maturity2024/06/01
Coupon/express payment6.250%
Coupon stylefix
Final redemption barrier in %50.00%
Nominal amount1,000.00
Quantono
First trading day2020/06/01
Last trading day2024/05/28

Express bonds | Description

This express bond refers to the shares of Biogen Inc and Amgen Inc. Regardless of the performance of the underlyings, there is an annual interest payment of 6.25 % p.a. The bond will be redeemed on 01/06/2024 if there is no automatic early redemption.

There is an automatic early redemption, if the closing price of both underlyings is at or above the strike price on one of the valuation dates (25/05/2021, 25/05/2022, 25/05/2023). In this case investors receive the respective early redemption amount of 100.00 % of the nominal amount on the early repayment date (01/06).

If the express bond has not been redeemed early, there are two possibilities at maturity:

1. If the closing price of the underlying with the worst performance is at or above the final-redemption-barrier on the last valuation date (28/05/2024), investors receive the nominal amount (1,000 EUR) plus the interest payment of 6.25 % for the final year.

2. If the closing price of the underlying with the worst performance is below the final-redemption-barrier on the last valuation date, then investors receive the nominal amount multiplied by the performance of the underlying with the worst performance (worst-of). In addition the interest payment of 6.25 % for the final year is paid. In this case, there is a capital loss.

Price information

Today open98.50
Today high98.60
Today low98.50
Close (previous day)99.25
Spread in %-
Spread absolute-
Spread harmonised-
High price (52 weeks)103.05
Low price (52 weeks)91.70

Performance

Performance YTD in %+2.23%
Performance 1 month in %+0.31%
Performance 6 months in %-1.60%
Performance 1 year in %+4.89%
Performance 3 years in %-2.71%
Performance 5 years in %-
Performance since inception in %-1.40%


2023/09/29 17:25:24
Bid Ask
98.10 -
Difference -0.65% (-0.65)

Date: 2023/09/29 22:00:00
Underlying Quote
257.01 USD
Difference -0.32% (-0.82)

General attributes underlying

NameBIOGEN
ISINUS09062X1037
Stock exchange (underlying)NMS
Currency (underlying)USD
Price257.01
Time23/09/29 - 22:00:00
Start value underlying307.0900
Strike price307.0900
Final redemption barrier153.5450
Final redemption barrier distance103.47
Final redemption barrier distance in %40.26%
No of shares for redemption-
Today high259.23
Today low255.25
High price (52 weeks)319.76
Low price (52 weeks)250.31
Add barriers
Interactive chart


Information about previous performance does not guarantee future performance.
Source: FactSet

Know-How

In our know-how area you can find all relevant details on the different types of certificates. The tutorial gives you selected information about the functionality of structured products and assists you in making your investment decision.

Contact

Do you have any further questions which are not covered in our know-how area? Please ask directly our product specialists via our contact form.



Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.